ArticleBiomedicines2021

The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model.

Philipp Schwabl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.